Prostate News and Research

RSS

Avastin study shows significant improvement in patients with metastatic colorectal cancer

Genentech, Inc. and Roche have announced that the New England Journal of Medicine published the first Phase III study of an anti-angiogenesis cancer therapy, showing that the addition of Avastin™ (bevacizumab) to the IFL chemotherapy regimen (5-FU/Leucovorin/ CPT-11) significantly extended survival in patients with first-line (previously untreated) metastatic colorectal cancer.

2 Jun 2004

Health Canada serious warning against use of Thermonex capsules

Health Canada is warning consumers not to use Thermonex capsules, which are being advertised for weight loss, water loss and to help boost thyroid output. This product could cause serious adverse effects, including death.

1 Jun 2004

Smoking a lot more harmful than previously thought

The U.S. Surgeon General has released a new comprehensive report on smoking and health, revealing for the first time that smoking causes diseases in nearly every organ of the body. Published 40 years after the surgeon general's first report on smoking -- which concluded that smoking was a definite cause of three serious diseases -- this newest report finds that cigarette smoking is conclusively linked to diseases such as leukemia, cataracts, pneumonia and cancers of the cervix, kidney, pancreas and stomach.

30 May 2004

Physicians need to understand comorbidities to better help cancer patients

Findings from a new cancer study may seem obvious — a patient’s overall health is a critical factor in assessing prognosis. But the study’s authors say data about patients’ non-cancer ailments, called comorbidities, are not currently incorporated into cancer statistics.

27 May 2004

Current test for prostate cancer is inadequate

Britain’s top cancer scientists claim that men’s health is at risk because the current test for prostate cancer is inadequate. The warning comes as The Institute of Cancer Research launches the 7th Everyman Male Cancer Awareness Month to alert men to the risk of prostate and testicular cancer.

27 May 2004

Smoking causes diseases in nearly every organ of the body

U.S. Surgeon General Richard H. Carmona today released a new comprehensive report on smoking and health, revealing for the first time that smoking causes diseases in nearly every organ of the body.

27 May 2004

Radiation therapy after surgery for men with prostate cancer lessens the chance of the cancer returning

Radiation therapy after surgery for men with prostate cancer lessens the chance of the cancer coming back, regardless of whether the radiation was administered immediately after surgery or after the cancer recurred, according to a new study in the June 2004 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology.

27 May 2004

Evidence that abnormally short telomeres play a role in the early development of cancer

Scientists at the Johns Hopkins Kimmel Cancer Center say they have evidence that abnormally short telomeres - the end-caps on chromosomes that normally preserve genetic integrity -appear to play a role in the early development of many types of cancer.

27 May 2004

Men with low prostate specific antigen levels on screening tests can still have prostate cancer

Men with low PSA (prostate specific antigen) levels on screening tests can still have prostate cancer, according to a study* released today by scientists from the National Cancer Institute (NCI).

27 May 2004

3 or 4 glasses of wine a week can kill cancer cells

It’s well known that drinking red wine in moderation can have some health benefits, mainly attributed to a compound called resveratrol. Now, scientists at the University of Virginia Health System have discovered how.

25 May 2004

50 percent of British men admit they would delay seeing a doctor if they had warning signs of cancer

Younger men were most likely to cite embarrassment as a reason to delay getting their symptoms checked, whereas those in the 45+ age group were concerned about what the doctor might find as the result of an examination. Lack of time was a factor across all groups.

25 May 2004

Some people more at risk of obesity due to genetic makeup

Some people may have a higher risk of obesity because they are genetically predisposed to overeat or lead a sedentary lifestyle, a leading Cancer Research UK scientist will told conference delegates last week.

24 May 2004

Prostate Robotic System that will improve the diagnosis and treatment of prostate cancer

The Singapore General Hospital and Nanyang Technological University (NTU) have jointly developed a Prostate Robotic System that will improve the diagnosis and treatment of prostrate cancer, the fifth most common cancer in Singaporean men.

21 May 2004

Protein that appears to play a key role in Alzheimer's disease

A protein that allows human cancer to resist multiple anticancer drugs also appears to play a key role in Alzheimer's disease, according to research conducted at Fox Chase Cancer Center. The protein, active in brain tissue, could be a target for new drugs to treat patients with Alzheimer's.

20 May 2004

$First drug approved for hormone refractory prostate cancer that has shown a survival benefit$

First drug approved for hormone refractory prostate cancer that has shown a survival benefit

The the Food and Drug Administration (FDA) approved Taxotere (docetaxel), injection in combination with prednisone ( a steroid), for the treatment of patients with advanced metastatic prostate cancer. This is the first drug approved for hormone refractory prostate cancer that has shown a survival benefit.

19 May 2004

Obesity epidemic and its impact on prostate cancer

Recent federal reports have identified obesity as epidemic in the United States, and that that greater body mass index can be associated with a number of debilitating health conditions, such as heart disease and diabetes.

12 May 2004

Leading experts to shed light on controversial testosterone therapy treatment

The use of testosterone therapy will be the topic of a special panel briefing to be held during the 99th Annual Scientific Meeting of the American Urological Association on May 11, 2004 in the Moscone Center in San Francisco.

12 May 2004

Botox shows promise as an alternative treatment for benign prostatic hyperplasia

Injections of botulinum toxin A (botox) into the prostate are a promising alternative treatment for the millions of men who have benign prostatic hyperplasia (BPH), a condition commonly referred to as enlarged prostate, according to a study conducted by the University of Pittsburgh School of Medicine and Chang Gung Memorial Hospital in Taiwan.

11 May 2004

Sexual Dysfunction in benign prostatic hyperplasia (BPH) twice as high as physicians estimate

The incidence of sexual dysfunction in patients suffering from Benign Prostatic Hyperplasia (BPH) -- or enlarged prostate -- is nearly twice as high as treating physicians believe shows a new survey from the American Foundation for Urologic Diseases (AFUD) presented today at the American Urological Association annual meeting.

11 May 2004

Quality of life for men after prostate cancer treatment

Four to eight years after men undergo treatment for prostate cancer, they continue to see changes – both positive and negative – in their quality of life because of that treatment, researchers at the University of Michigan Health System and Harvard Medical School report.

11 May 2004

Prostate News and Research

Avastin study shows significant improvement in patients with metastatic colorectal cancer

Health Canada serious warning against use of Thermonex capsules

Smoking a lot more harmful than previously thought

Physicians need to understand comorbidities to better help cancer patients

Current test for prostate cancer is inadequate

Smoking causes diseases in nearly every organ of the body

Radiation therapy after surgery for men with prostate cancer lessens the chance of the cancer returning

Evidence that abnormally short telomeres play a role in the early development of cancer

Men with low prostate specific antigen levels on screening tests can still have prostate cancer

3 or 4 glasses of wine a week can kill cancer cells

50 percent of British men admit they would delay seeing a doctor if they had warning signs of cancer

Some people more at risk of obesity due to genetic makeup

Prostate Robotic System that will improve the diagnosis and treatment of prostate cancer

Protein that appears to play a key role in Alzheimer's disease

First drug approved for hormone refractory prostate cancer that has shown a survival benefit

Obesity epidemic and its impact on prostate cancer

Leading experts to shed light on controversial testosterone therapy treatment

Botox shows promise as an alternative treatment for benign prostatic hyperplasia

Sexual Dysfunction in benign prostatic hyperplasia (BPH) twice as high as physicians estimate

Quality of life for men after prostate cancer treatment

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News